Methoxyetomidate Hydrochloride

盐酸莫托咪酯

Report date: 2026/02/24 20:00:16
NME

Base Information

Drug NameMethoxyetomidate Hydrochloride
Drug Alias Name甲氧依托咪酯甲氧依托咪酯盐酸盐ET-26
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors
Targets11-beta-hydroxysteroid dehydrogenase
Therapy Area/IndicationsSedationPharmaceutical aidsHeart Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAhon Pharmaceutical Co LtdWest China Hospital Of Sichuan UniversityJinzhou Aohong Pharmaceutical Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsSedationPharmaceutical aidsHeart Diseases +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A